Literature DB >> 1730948

The extended frontal approach to tumors of the anterior, middle, and posterior skull base.

L N Sekhar1, A Nanda, C N Sen, C N Snyderman, I P Janecka.   

Abstract

The extended frontal approach is a modification of the transbasal approach of Derome. The addition of a bilateral orbitofrontal or orbitofrontoethmoidal osteotomy improves the exposure of midline lesions of the anterior, middle, and posterior skull base, while minimizing the need for frontal lobe retraction. The authors present a 5-year experience with 49 patients operated on via the extended frontal approach. In seven patients, the extended frontal approach was used alone; in the remaining 42, it was combined with other skull base approaches. Highly malignant tumors were removed en bloc, whereas benign tumors and low-grade malignancies were removed either en bloc or piecemeal. Reconstruction was usually performed using fascia lata, a pericranial flap, and/or autologous fat. A temporalis muscle flap or a distant microvascular free flap was required for some patients. One patient died 1 month postoperatively due to superior mesenteric artery thrombosis. Three patients had postoperative infections, two had cerebrospinal fluid leaks requiring reoperation, and four had brain contusions or hematomas. All but two patients recovered to their preoperative functional level. After an average follow-up period of 26 months (range 6 to 56 months), 64% of patients with benign lesions, 64% of patients with low-grade malignancies, and 44% of patients with high-grade lesions were alive with no evidence of disease.

Entities:  

Mesh:

Year:  1992        PMID: 1730948     DOI: 10.3171/jns.1992.76.2.0198

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  36 in total

1.  Classification and surgical approaches for transnasal endoscopic skull base chordoma resection: a 6-year experience with 161 cases.

Authors:  Songbai Gui; Xuyi Zong; Xinsheng Wang; Chuzhong Li; Peng Zhao; Lei Cao; Yazhuo Zhang
Journal:  Neurosurg Rev       Date:  2016-02-03       Impact factor: 3.042

2.  Transcranial resection of olfactory neuroblastoma.

Authors:  Chih-Chun Wang; Yao-Liang Chen; Yung-Shin Hsu; Shih-Ming Jung; Sheng-Po Hao
Journal:  Skull Base       Date:  2005-08

3.  Quantification of the advantages of the extended frontal approach to skull base.

Authors:  Rajesh Acharya; Mark Shaya; Ravi Kumar; Gloria C Caldito; Anil Nanda
Journal:  Skull Base       Date:  2004-08

4.  Endoscopic and Microscopic Extended Subfrontal Approach to the Clivus: A Comparative Anatomical Study.

Authors:  Pietro Mortini; Fabio Roberti; Chandrasekar Kalavakonda; Amal Nadel; Laligam N Sekhar
Journal:  Skull Base       Date:  2003-08

5.  Advances in surgical management of malignancies of the cranial base: the extended transbasal approach.

Authors:  James P Chandler; Harold J Pelzer; Bernard B Bendok; H Hunt Batjer; Sean A Salehi
Journal:  J Neurooncol       Date:  2005-06       Impact factor: 4.130

6.  Extended transbasal approach: anatomy, technique, and indications.

Authors:  S Terasaka; J D Day; T Fukushima
Journal:  Skull Base Surg       Date:  1999

7.  Craniofacial resection: decreased complication rate with a modified subcranial approach.

Authors:  D A Ross; L J Marentette; C E Moore; K L Switz
Journal:  Skull Base Surg       Date:  1999

8.  The Role of the Pterional Approach in the Surgical Treatment of Olfactory Groove Meningiomas: A 20-year Experience.

Authors:  Andrej D Bitter; Lampis C Stavrinou; Georgios Ntoulias; Athanasios K Petridis; Morina Dukagjin; Martin Scholz; Werner Hassler
Journal:  J Neurol Surg B Skull Base       Date:  2013-01-22

9.  Critical appraisal of extent of resection of clival lesions using the expanded endoscopic endonasal approach.

Authors:  Aaron R Cutler; Jagmeet S Mundi; Noriko Solomon; Jeffrey D Suh; Marilene B Wang; Marvin Bergsneider
Journal:  J Neurol Surg B Skull Base       Date:  2013-04-12

Review 10.  Adjuvant radiation therapy and chondroid chordoma subtype are associated with a lower tumor recurrence rate of cranial chordoma.

Authors:  Brian J Jian; Orin G Bloch; Isaac Yang; Seunggu J Han; Derick Aranda; Tarik Tihan; Andrew T Parsa
Journal:  J Neurooncol       Date:  2009-12-02       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.